Deals
Takeda Moves to Join Pharma Giants With $62 Billion Shire Deal
- Japanese drugmaker secures $31 billion bridge loan from banks
- CEO Weber says deal transforms company, giving it global reach
This article is for subscribers only.
Takeda Pharmaceutical Co. is joining the drug industry’s giants with Japan’s biggest overseas takeover -- a $62 billion deal for much larger rival Shire Plc.
Chief Executive Officer Christophe Weber capped a drawn-out pursuit of the U.K.-listed company with an acquisition he described as transformational that will give Takeda wider reach into the world’s biggest drug market and strengthen its global pipeline for lucrative drugs that treat rare diseases.